C. Randal Mills

C. Randal Mills discloses dealings in 2 companies, chiefly Elutia Inc. and Osiris Therapeutics, Inc. We count 36 filings; the first trade dates from 5 August 2009 and the latest from 10 September 2026.

Purchases make up the whole of the open-market record (5 purchases, €13k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 14 share grants and 15 option exercises.

Half of the purchases are above €2,607 and half below. On 2 out of 5 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +43.8%. These figures describe past trades and do not predict future prices.

On 14 September 2026 came the latest disclosure, an option exercise in Elutia Inc. The last purchase on record was published on 18 December 2025, which is 325 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.